Evaluating gliclazide for the treatment of type 2 diabetes mellitus
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2141108
Abstract: ABSTRACT Introduction Sulfonylureas have been the standard second-line treatment after failure of metformin monotherapy in patients with type 2 diabetes (T2D) but they are becoming less popular as the newer glucose-lowering agents have a relatively… read more here.
Keywords: evaluating gliclazide; gliclazide treatment; glucose lowering; type diabetes ... See more keywords